NEW YORK (GenomeWeb) – Belgian personalized cancer firm OncoDNA said today it has been awarded a contract to conduct testing and analysis for the Breast International Group (BIG), a Brussels non-profit that funds breast cancer research.

Under the multi-year contract, OncoDNA will perform its OncoDEEP Clinical Plus test on primary and metastatic tumor and blood samples from BIG's AURORA breast cancer clinical research program, which launched on April 15.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.

Stanford University researchers are studying top athletes to uncover genes linked to performance.

The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.